Finnrick - Ensuring a Safer and More Transparent Supply Chain
NUPEPS Peptides

NUPEPS Peptides

Retatrutide

Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from NUPEPS Peptides on 16 Dec 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
Tentative Rating
NUPEPS Peptides
Retatrutide
Tested 2 Samples
Last test 16 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from NUPEPS Peptides

Samples are tested in commercial labs

Tests Count

2

Scores

AVG9.5MIN9.3MAX9.8

Last

16 Dec 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
16 Dec 2025View9.320mg21.3mg+6.5%99.80%R1120251102-20White Label / Silver Crimp / Blue Cap Lab GVendor
16 Dec 2025View9.820mg19.8mg-1.0%99.80%R1120251102-20White Label / Silver Crimp / Blue Cap Lab GVendor

Launch with Finnrick

Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.

The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.

The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.